MTRI insider trading
InMed Pharmaceuticals Inc.
In the past 68 days, 1 insider bought $35K of InMed Pharmaceuticals Inc. stock in 1 open-market purchase. The largest purchase was $35K by ADAR1 Capital Management, LLC (10% owner) on Nov 5, 2026.
Insider purchases
| Insider | Value | Holdings | Signal | Traded / filed |
|---|---|---|---|---|
ADAR1 Capital Management, LLC 10% owner |
$35K 2,640 sh @ $13.10 |
+2.8% | Low
|
Nov 5, 2026 Filed Nov 9, 2026 |
Insider sales
No open-market sales by insiders in this period.
The week's top insider buys, every Monday
Clusters, CEO purchases and the largest buys from the past week's SEC filings. One free email a week.
Unsubscribe any time. No spam, no stock picks.